Logo image of JLHL

JULONG HOLDING LTD (JLHL) Stock Fundamental Analysis

USA - NASDAQ:JLHL - KYG5500K1022 - Common Stock

4.155 USD
-0.02 (-0.5%)
Last: 9/16/2025, 8:00:02 PM
4.13 USD
-0.03 (-0.6%)
After Hours: 9/16/2025, 8:00:02 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to JLHL. JLHL was compared to 52 industry peers in the Construction & Engineering industry. While JLHL has a great health rating, its profitability is only average at the moment. JLHL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

JLHL had positive earnings in the past year.
In the past year JLHL had a positive cash flow from operations.
JLHL Yearly Net Income VS EBIT VS OCF VS FCFJLHL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

With a decent Return On Assets value of 9.87%, JLHL is doing good in the industry, outperforming 76.92% of the companies in the same industry.
With an excellent Return On Equity value of 98.28%, JLHL belongs to the best of the industry, outperforming 98.08% of the companies in the same industry.
JLHL has a Return On Invested Capital of 97.74%. This is amongst the best in the industry. JLHL outperforms 100.00% of its industry peers.
JLHL had an Average Return On Invested Capital over the past 3 years of 42.49%. This is significantly above the industry average of 17.22%.
The 3 year average ROIC (42.49%) for JLHL is below the current ROIC(97.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.87%
ROE 98.28%
ROIC 97.74%
ROA(3y)6.96%
ROA(5y)N/A
ROE(3y)45.35%
ROE(5y)N/A
ROIC(3y)42.49%
ROIC(5y)N/A
JLHL Yearly ROA, ROE, ROICJLHL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 20 40 60 80

1.3 Margins

JLHL's Profit Margin of 9.83% is amongst the best of the industry. JLHL outperforms 86.54% of its industry peers.
JLHL has a better Operating Margin (11.52%) than 80.77% of its industry peers.
JLHL has a Gross Margin of 15.30%. This is comparable to the rest of the industry: JLHL outperforms 48.08% of its industry peers.
Industry RankSector Rank
OM 11.52%
PM (TTM) 9.83%
GM 15.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JLHL Yearly Profit, Operating, Gross MarginsJLHL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so JLHL is creating value.
Compared to 1 year ago, JLHL has about the same amount of shares outstanding.
There is no outstanding debt for JLHL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
JLHL Yearly Shares OutstandingJLHL Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
JLHL Yearly Total Debt VS Total AssetsJLHL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M

2.2 Solvency

JLHL has an Altman-Z score of 4.05. This indicates that JLHL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.05, JLHL is in the better half of the industry, outperforming 67.31% of the companies in the same industry.
There is no outstanding debt for JLHL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.05
ROIC/WACC11.34
WACC8.62%
JLHL Yearly LT Debt VS Equity VS FCFJLHL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

JLHL has a Current Ratio of 1.08. This is a normal value and indicates that JLHL is financially healthy and should not expect problems in meeting its short term obligations.
JLHL has a worse Current ratio (1.08) than 71.15% of its industry peers.
JLHL has a Quick Ratio of 1.08. This is a normal value and indicates that JLHL is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.08, JLHL is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
JLHL Yearly Current Assets VS Current LiabilitesJLHL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

JLHL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.15%, which is quite impressive.
Looking at the last year, JLHL shows a very strong growth in Revenue. The Revenue has grown by 45.82%.
EPS 1Y (TTM)52.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.15%
Revenue 1Y (TTM)45.82%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%45.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JLHL Yearly Revenue VS EstimatesJLHL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 50M 100M 150M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 37.77, the valuation of JLHL can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of JLHL is on the same level as its industry peers.
JLHL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.20.
Industry RankSector Rank
PE 37.77
Fwd PE N/A
JLHL Price Earnings VS Forward Price EarningsJLHL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

JLHL's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. JLHL is more expensive than 65.38% of the companies in the same industry.
JLHL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. JLHL is cheaper than 94.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.17
EV/EBITDA 30.35
JLHL Per share dataJLHL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

JLHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

JLHL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JULONG HOLDING LTD

NASDAQ:JLHL (9/16/2025, 8:00:02 PM)

After market: 4.13 -0.03 (-0.6%)

4.155

-0.02 (-0.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap89.12M
AnalystsN/A
Price TargetN/A
Short Float %0.37%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 37.77
Fwd PE N/A
P/S 3.65
P/FCF 9.17
P/OCF 9.16
P/B 36.5
P/tB 36.5
EV/EBITDA 30.35
EPS(TTM)0.11
EY2.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.45
FCFY10.91%
OCF(TTM)0.45
OCFY10.91%
SpS1.14
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.87%
ROE 98.28%
ROCE 115.16%
ROIC 97.74%
ROICexc N/A
ROICexgc N/A
OM 11.52%
PM (TTM) 9.83%
GM 15.3%
FCFM 39.84%
ROA(3y)6.96%
ROA(5y)N/A
ROE(3y)45.35%
ROE(5y)N/A
ROIC(3y)42.49%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)53.4%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 5.69%
Cap/Sales 0.01%
Interest Coverage 2223.33
Cash Conversion 342.29%
Profit Quality 405.18%
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 4.05
F-Score6
WACC8.62%
ROIC/WACC11.34
Cap/Depr(3y)13.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)45.82%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%45.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y604.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y607.82%
OCF growth 3YN/A
OCF growth 5YN/A